Kim often keeps patients at lower doses longer rather than pushing quickly to the maximum dose
Ethics declarations Conflict of interest F.C.S declares grants from NIH/NIDDK (P30 DK040561, U24 DK132733, and UE5 DK137285) and consulting fees from Eli Lilly, Novo Nordisk, Amgen, Boehringer Ingelheim, AstraZeneca, AbbVie, Currax, Pfizer, Doximity, MelliCell, Vida Health, Empros Pharma, Apnimed, Clearmind Medicine, and Ilant Health, all outside of the current work
Metabolic surgery triggers a complex cascade of hormonal and metabolic changes that influence hunger, satiety and fat metabolism
Glucagon-Like Peptide 1-Based Therapies for the Treatment of Type 2 Diabetes Mellitus. Edited by David M Nathan and Katya Rubinow, UpToDate, Wolters Kluwer, 9 Nov
Initially approved for type 2 diabetes management, recent studies highlight their potential in weight management and improving heart health in obese individuals